| Not Yet Recruiting | ED Patient's Perceptions and Acceptability Toward a Novel POC HCV Viral Load Testing NCT03767231 | Johns Hopkins University | N/A |
| Not Yet Recruiting | A Phase 1 Clinical Trial of Adjuvanted Protein-based HCV Vaccine Candidates (HCV Vaccine Trial) NCT07237282 | University of Alberta | Phase 1 |
| Not Yet Recruiting | Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women With Hepa NCT07040319 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 / Phase 2 |
| Not Yet Recruiting | Pan-Viral Screening and Linkage to Care Among GBMSM and Trans Women in Spain NCT07085715 | Fundació Institut Germans Trias i Pujol | — |
| Recruiting | C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV NCT07037277 | Atea Pharmaceuticals, Inc. | Phase 3 |
| Recruiting | DBS TaT in Peer-assisted Telemedicine for Hepatitis C NCT06409169 | Oregon Health and Science University | N/A |
| Not Yet Recruiting | Lay User Evaluation of the Panbio™ HCV Self Test in an EU Population NCT06492018 | Abbott Rapid Dx | — |
| Recruiting | Simplifying Hepatitis C Pathways for People Who Inject Drugs in Armenia, Georgia, and Tanzania NCT06159504 | Médecins du Monde | EARLY_Phase 1 |
| Not Yet Recruiting | A Study Done by a Demonstrator and Two Professors in Public Health and Community Medicine Department in Facult NCT06316492 | Assiut University | — |
| Not Yet Recruiting | Hepatitis C Treatment in Idaho County Jails NCT06533319 | Eastern Idaho Public Health | N/A |
| Terminated | Hepatitis C Lab Testing Comparison Study NCT06380166 | HealthPartners Institute | — |
| Recruiting | HCV Tappt Adherence Study NCT06263829 | University of Illinois at Chicago | N/A |
| Not Yet Recruiting | Implementation of a Re-engagement Program for Hepatitis C Patients Lost to Follow-up in Argentina. NCT06373198 | Hospital El Cruce | — |
| Recruiting | Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs NCT06179498 | University of California, San Francisco | N/A |
| Unknown | Re-link HCV in Substance-Use Telemedicine Program NCT06349902 | trueNorth Medical Centres | — |
| Unknown | UHN Inpatient Hepatitis C & B Screening NCT04620226 | Jordan Feld | Phase 4 |
| Recruiting | Feasibility and Acceptability of HCV Treatment in Pregnancy NCT06367465 | Washington University School of Medicine | — |
| Unknown | Hepatitis C Virus Self-testing (HCVST) in Sexual and Gender Minorities in Rio de Janeiro NCT06203925 | Oswaldo Cruz Foundation | — |
| Completed | Delivering a Multi-disease Screening Tool to Migrant Populations NCT05868005 | Barcelona Institute for Global Health | N/A |
| Completed | INSTI® HCV (Hepatitis C Virus) Antibody Self-Test Contrived Result Interpretation NCT06357819 | bioLytical Laboratories | — |
| Completed | Trial of Hepatitis C Self-Testing in the Hands of Untrained Lay Users NCT06369116 | bioLytical Laboratories | N/A |
| Unknown | Awareness of Osteoporosis in Patients With Hepatitis C Infection NCT05769400 | Uskudar State Hospital | — |
| Enrolling By Invitation | Therapy for Hepatitis C Virus (HCV) in Primary Treatment Failure in Pakistan NCT05248919 | Queen Mary University of London | N/A |
| Completed | A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCV NCT05904470 | Atea Pharmaceuticals, Inc. | Phase 2 |
| Completed | HCV Microfluidic Diagnostics NCT06047275 | University of Hull | — |
| Unknown | Epidemiology of Occult Hepatitis C Virus Infection in Patients Born Before 1969 in the Hospital Setting: a Spo NCT05813691 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Unknown | Multicenter Performance Study of QuadQuik Invitro Diagnostic Device NCT05692505 | Genlantis Diagnostics | — |
| Unknown | A Study of Chronic Hepatitis C Patients Treated With SOF/VEL/VOX NCT06010524 | Cerrahpasa Medical Faculty Foundation | — |
| Recruiting | The National Australian HCV Point-of-Care Testing Program - HCV Antibody Testing Minimal Dataset NCT05713136 | Kirby Institute | — |
| Active Not Recruiting | Buprenorphine Integration Research and Community Health NCT05668780 | Yale University | N/A |
| Completed | Hepatitis C Screening Alerts NCT05710120 | Epividian | — |
| Completed | Hepatitis C Diagnosis to Treatment Management NCT05725109 | Epividian | — |
| Recruiting | Screening for Hepatitis B, Hepatitis C and AIDS Viruses Using Dried Blood Spot NCT05390424 | University Hospital, Rouen | N/A |
| Completed | ASAP: Access to Syringes at Pharmacies for the Prevention of Bloodborne Infections Among People Who Inject Dru NCT05270135 | University of Arizona | N/A |
| Completed | Criminal Justice Coordinated Transitional Care NCT05376371 | University of Wisconsin, Madison | N/A |
| Terminated | HCV Test and Treat Utilizing Simplified HCV Patient Education NCT05582681 | Weill Medical College of Cornell University | Phase 4 |
| Unknown | Hepatic Enzymes, Psychological Measures, and Sexual Dysfunction Responses to Aerobic Exercise in Hepatitis-C M NCT05624086 | Cairo University | N/A |
| Active Not Recruiting | Tele-Harm Reduction NCT05208697 | University of Miami | N/A |
| Completed | Hepatitis C Prevalence in Men Who Have Sex With Men NCT06606197 | Consorci Sanitari de l'Alt Penedès i Garraf | — |
| Unknown | Efficacy and Safety of SOF/VEL + RBV and SOF/VEL/VOX for 12 Weeks in HCV Subjects With GT3b and Compensated Ci NCT05467826 | Peking University People's Hospital | Phase 4 |
| Completed | Hepatitis C Treatment in Probation and Parole Office NCT05413785 | Jens Rosenau | N/A |
| Completed | Study to Evaluate the Possible Antifibrotic Effect of Zinc Sulphate in Chronic HCV Patient Receiving Direct Ac NCT05465434 | Tanta University | Phase 3 |
| Active Not Recruiting | Enhancing Hepatitis C Testing and Treatment Among People Who Inject Drugs Attending Needle and Syringe Program NCT04014179 | Kirby Institute | N/A |
| Completed | Preparing for the Final Phase of Hepatitis C Elimination. Cairns Final 30% NCT05264558 | Macfarlane Burnet Institute for Medical Research and Public Health Ltd | Phase 4 |
| Unknown | Safety and Efficacy of Decentralized HCV Treatment vs Standard-of-Care in Rio de Janeiro (Brazil) NCT06306300 | Oswaldo Cruz Foundation | Phase 4 |
| Terminated | Utilization of MAsS in Patients Undergoing LT for HCC NCT05184283 | Columbia University | — |
| Completed | Ablation of Hepatocellular Carcinoma: a Nationwide Study NCT05498779 | Rigshospitalet, Denmark | — |
| Unknown | Rural New England Health Study (Phase 2) NCT05466331 | Baystate Medical Center | N/A |
| Unknown | Treatment of Hepatitis c by Using Direct-acting Antiviral NCT05372874 | Tanta University | — |
| Unknown | Australian Hepatitis and Risk Survey in Prisons NCT05839522 | Kirby Institute | — |
| Completed | Community Versus Facility-based Services to Improve the Screening of Active HCV Infection in Cambodia NCT03992313 | ANRS, Emerging Infectious Diseases | N/A |
| Unknown | HCV Treatment Initiation During Acute Psychiatric Admission NCT04625322 | University Health Network, Toronto | Phase 4 |
| Recruiting | Use of a Patient-Centered Electronic App to Increase ED Patient's Knowledge on HCV to Improve the HCV Care Con NCT04162938 | Johns Hopkins University | N/A |
| Unknown | Hepatitis C Screening Paired With Mammography NCT05067374 | University Hospital, Montpellier | — |
| Unknown | Same-visit Hepatitis C Testing and Treatment (The QuickStart Study) NCT05016609 | Macfarlane Burnet Institute for Medical Research and Public Health Ltd | Phase 4 |
| Completed | Health and Migration Trajectories of Housekeepers in Bamako NCT05472051 | ANRS, Emerging Infectious Diseases | — |
| Recruiting | The Australian HCV Point-of-Care Testing Program NCT05042544 | Kirby Institute | — |
| Completed | Providing PrEP, Hepatitis C Treatment, and MOUD Through Telemedicine at Greensboro SSP NCT05108935 | Duke University | N/A |
| Recruiting | The Treatment in Pregnancy for Hepatitis C ("TiP-HepC") Registry NCT05368974 | The Task Force for Global Health | — |
| Completed | Estimation of the Prevalence of HIV, Hepatitis C and Hepatitis B Infection Among Detainees in the Nîmes Admini NCT05127187 | Centre Hospitalier Universitaire de Nīmes | N/A |
| Unknown | Acceptance of Hepatitis C Screening by Self-testing in High Risk and General Population NCT05146609 | University of La Laguna | N/A |
| Unknown | Screening for Hepatitis C Using a Rapid Diagnostic Orientation Test (TROD) in Patients Over 50 Years Old in th NCT05103085 | Hôpital Européen Marseille | — |
| Withdrawn | Hepatitis C Treatment Study in Myanmar NCT03158857 | Myanmar Oxford Clinical Research Unit | — |
| Completed | Radomised Phase II Study of MTL-CEBPA Plus Sorafenib or Sorafenib Alone NCT04710641 | Mina Alpha Limited | Phase 2 |
| Active Not Recruiting | Advanced Care Coordination and Enhanced Linkage and Retention Among Transitional Re-Entrants NCT04701437 | Montefiore Medical Center | N/A |
| Unknown | HCV Self-testing in Georgia NCT04961723 | Foundation for Innovative New Diagnostics, Switzerland | N/A |
| Recruiting | The National Australian HCV Point-of-Care Testing Program - Minimal Dataset NCT05248555 | Kirby Institute | — |
| Unknown | HCV Self-testing in Pakistan NCT04971538 | Foundation for Innovative New Diagnostics, Switzerland | N/A |
| Unknown | Prospective Cohort Study on Prognosis of Patients With Hepatitis B/C NCT05102838 | Sun Yat-sen University | — |
| Completed | Tajik Migrant Health Education Study NCT04853394 | University of Illinois at Chicago | N/A |
| Unknown | Systematic Screening for Viral Hepatitis B and C at the PASS Consultation of the Montpellier University Hospit NCT04959643 | University Hospital, Montpellier | — |
| Withdrawn | Study of AT-777 in Healthy Subjects and AT-777 in Combination With AT-527 in HCV-Infected Subjects NCT04309734 | Atea Pharmaceuticals, Inc. | Phase 1 / Phase 2 |
| Unknown | HCV Self-testing in Malaysia NCT04982718 | Foundation for Innovative New Diagnostics, Switzerland | N/A |
| Completed | Eliminating HCV in Rural South Carolina Utilizing NP Led Mobile Clinics and Virtual Care Coordination NCT05369507 | Prisma Health-Upstate | N/A |
| Completed | HepC Micro-elimination on MSM and TGW Population. NCT06847958 | Projecte dels NOMS Hispanosida | — |
| Completed | Hepatitis C in Severe Mental Disorders: Nursing Programme NCT04891445 | Hospital Regional de Malaga | N/A |
| Completed | Prevention of Transmission of Hepatitis C Virus (HCV) From HCV-Viremic Organ Donor NCT04596475 | University of California, San Diego | Phase 1 / Phase 2 |
| Completed | Plasma MicroRNA for Prediction of Hepatocellular Carcinoma NCT05449847 | Benha University | — |
| Terminated | QUICKly Eradicate Hepatitis C in Patients Undergoing REnal Transplant With 4 Weeks of Glecaprevir/Pibrentasvir NCT04515797 | Massachusetts General Hospital | Phase 4 |
| Completed | Management of Hepatitis C in HIV Infected Injection Drug Users (IDUs) NCT01448915 | Johns Hopkins University | — |
| Completed | 8- Versus 12-week of Sofosbuvir-ravidasvir Treatment of Chronic Hepatitis C NCT04885855 | Muhammad Radzi Abu Hassan | Phase 2 / Phase 3 |
| Completed | A Cross Sectional Observational Study on Relation Between Oral Manifestation and Hepatitis C in Egypt NCT04812990 | Misr University for Science and Technology | — |
| Completed | Occult HCV Infection After DAAD Treatment in Haemodialysis Patients NCT04719338 | Alexandria University | N/A |
| Unknown | Treatment of HOsPitalised Inpatients for Hepatitis C (TOPIC): Therapeutic Intervention Enhancing Care Linkage NCT03981211 | Kirby Institute | N/A |
| Completed | Increasing HCV Linkage to Care Among People Who Inject Drugs NCT04741750 | Family Health Centers of San Diego | N/A |
| Completed | Supporting Treatment Outcomes Among PWID NCT04652804 | Johns Hopkins University | N/A |
| Completed | Coaching for HCV and HIV NCT04314414 | Boston Medical Center | N/A |
| Completed | Study on the Prevalence of Hepatitis C In a psychiatRic Population NCT04600479 | Nantes University Hospital | N/A |
| Completed | HCV-Smoking Cessation Study NCT05466981 | Prisma Health-Upstate | N/A |
| Completed | Kidney Transplants in Hepatitis C Negative Recipients With Hepatitis C Viremic Donors NCT04575896 | Johns Hopkins University | Phase 4 |
| Completed | Hepatitis C Pharmacy-based Strategy for Injectors NCT04698629 | University of Washington | — |
| Unknown | Application of 18F-FDOPA PET in Research of the Association Between HCV Infection and Parkinson's Disease. NCT04618679 | National Taiwan University Hospital | — |
| Unknown | Evaluation of the Use of the GenXpert to Detect Hepatitis C RNA NCT04717856 | Hasselt University | N/A |
| Unknown | User-friendly HIV Testing and Counseling Services NCT04585165 | Institut de Recherche pour le Developpement | — |
| Completed | Enhancing Electronic Health Systems to Decrease the Burden of Colon Cancer, Lung Cancer, Obesity, Vaccine-Prev NCT04540081 | University of California, Davis | N/A |
| Completed | HCV Related Hepatocellular Carcinoma Recurrence After Directly Acting Antivirals: A Randomized Controlled Tria NCT04653818 | Alexandria University | Phase 4 |
| Suspended | Pilot Study on the Feasibility of Systematic Hepatitis C Screening of Hospitalized Patients NCT04405024 | Centre Hospitalier Intercommunal Creteil | N/A |
| Completed | Improving Inpatient Screening for Hepatitis C NCT04525690 | University of Pennsylvania | N/A |
| Active Not Recruiting | A Study to Evaluate Preemptive Therapy in Hepatitis C (HCV) Organ Transplant Recipients NCT04508907 | Mayo Clinic | Phase 4 |
| Unknown | Link Hepatitis C Notifications to Treatment in Tasmania NCT04510246 | Macfarlane Burnet Institute for Medical Research and Public Health Ltd | N/A |
| Unknown | Safety and Efficacy of Different Antiviral Regimens for Hepatitis C Virus Relapse NCT04662138 | Alexandria University | — |
| Withdrawn | STOP HCC: Mailed HCV Treatment Outreach Program for HCC Prevention for Elevated LFTs NCT04395118 | University of Texas Southwestern Medical Center | N/A |
| Completed | Ending Transmission of HIV, HCV, and STDs and Overdose in Rural Communities of People Who Inject Drugs (ETHIC) NCT04427202 | University of Chicago | N/A |
| Terminated | Testing of a Navigation Intervention for Hepatitis C and HIV NCT04499651 | University of California, Los Angeles | N/A |
| Completed | EPIC: Evaluation of Pharmacy-based Identification and Treatment of HCV NCT05412017 | Cool Aid Community Health Centre | N/A |
| Completed | TeleHepC Treatment Trial NCT04798521 | Oregon Health and Science University | N/A |
| Unknown | the Pulmonary Safety of Antihepatitis C Treatment NCT04122066 | Assiut University | — |
| Unknown | Telemedicine-based Model of Care for the Management of Hepatitis C Infected Patients NCT04411381 | University of La Laguna | N/A |
| Withdrawn | HCV + to HCV - Kidney Transplant NCT04320290 | Massachusetts General Hospital | Phase 4 |
| Completed | Community-Based, Client-Centered Prevention Homes to Address the Rural Opioid Epidemic- Aim 3 NCT04268173 | University of Wisconsin, Madison | N/A |
| Unknown | Strategic Treatment Reduction in Very Early Liver Disease With 4 Weeks Sofosbuvir Plus Glecepravir-pibrentasvi NCT03855917 | Kirby Institute | Phase 4 |
| Unknown | Leptin and Liver Enzymes Responses to Aerobic Training in Hepatitis c Patients NCT04550273 | Cairo University | N/A |
| Completed | Truenat™ HCV RNA Assay Evaluation NCT04236973 | Foundation for Innovative New Diagnostics, Switzerland | N/A |
| Unknown | Expression of Inflammasomes in HCV Patients NCT04244383 | Assiut University | Phase 4 |
| Recruiting | Liver Disease and Other Systemic Diseases NCT04525833 | Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation | — |
| Completed | Future Destinations: Journeys Towards Citizenship NCT04159545 | University of Dundee | — |
| Completed | Hepatitis C-Video vs. Brochure Education Delivery NCT04204447 | State University of New York at Buffalo | N/A |
| Unknown | GastrOesophageal Varices After Sustained Virological Response NCT04191018 | Oswaldo Cruz Foundation | — |
| Completed | Screening for Chronic Hepatitis C Virus in Hospitalized Patients NCT04437277 | Hospital St. Joseph, Marseille, France | N/A |
| Completed | The DETECT HCV Screening Trial NCT04003454 | Denver Health and Hospital Authority | N/A |
| Completed | The DETECT HCV Linkage to Care Trial NCT04026867 | Denver Health and Hospital Authority | N/A |
| Completed | Mobile Enhanced Prevention Support for People Leaving Jail NCT04036396 | University of California, Los Angeles | N/A |
| Unknown | Retrieval of Hepatitis C Patients Lost to Follow-up NCT04153708 | University of La Laguna | N/A |
| Completed | Prisons Evaluation of a One-stop-shop InterVentiOn NCT04809246 | Kirby Institute | N/A |
| Completed | Development and Pilot Testing of a PHCI for Emergency Department Patients Who Decline Rapid HIV/ HCV Screening NCT04137094 | Rhode Island Hospital | N/A |
| Completed | Reaching mEthadone Users Attending Community pHarmacies With HCV NCT03935906 | University of Dundee | N/A |
| Completed | Examining Hepatitis C Reinfection Rates in Kenya NCT03564639 | Yale University | — |
| Completed | Opportunstic Hepatitis C Virus Treatment NCT04220645 | University Hospital, Akershus | N/A |
| Completed | The Kentucky Viral Hepatitis Treatment Study NCT03949764 | Jennifer Havens | Phase 4 |
| Completed | Administration of Zepatier (Grazoprevir Plus Elbasvir) in Chronic Hemodialysis (HD) Patients With Hepatitis C NCT03365635 | University of Pennsylvania | Phase 4 |
| Completed | Zepatier in Patients with Substance Use NCT04048850 | University of Illinois at Chicago | — |
| Recruiting | The Hepatitis C Transplant Collaborative NCT04493385 | Baylor Research Institute | — |
| Completed | A TEst and Treat Intervention aMong Current People Who Inject Drugs With HCV Attending Needle and Syringe PrOg NCT03492112 | Kirby Institute | N/A |
| Completed | Association of Hepatitis C Virus With Breast Cancer NCT04090164 | Mansoura University | — |
| Withdrawn | HepATocellular Cancer Hcv Therapy Study NCT04546802 | Bayside Health | Phase 3 |
| Completed | The Use of Hepatitis C Positive Livers in Hepatitis C Negative Liver Transplant Recipients NCT03819322 | Fernanda P Silveira, MD, MS | Phase 2 |
| Withdrawn | HCV Post-Exposure Prophylaxis for Health Care Workers NCT03313414 | Massachusetts General Hospital | Phase 4 |
| Completed | Puglia HCV Micro-elimination Program NCT03923595 | Alessandra Mangia | — |
| Completed | Expanding the Pool in Lung Transplantation NCT03377478 | Pablo Sanchez | Phase 1 |
| Terminated | Hepatitis C Positive Organ to Recipient Hepatitis C Negative Longitudinal Transplant Study NCT04057001 | Yale University | — |
| Withdrawn | Hepatitis C Positive Donor Into Hepatitis C Negative Recipients NCT03702218 | University of Maryland, Baltimore | EARLY_Phase 1 |
| Completed | Study of AT-527 in Combination With Daclatasvir in Subjects With Hepatitis C Virus (HCV) Infection NCT04019717 | Atea Pharmaceuticals, Inc. | Phase 2 |
| Active Not Recruiting | The Use of Hepatitis C Positive Kidneys in Hepatitis C Negative Kidney Transplant Recipients NCT03809533 | Amit D Tevar, MD | Phase 2 |
| Completed | Trial for the Treatment of Acute Hepatitis C for 8 Weeks With Sofosbuvir/Velpatasvir NCT03818308 | Hannover Medical School | Phase 2 |
| Unknown | Strategies for Hepatitis C Testing and Treatment in Aboriginal Communities That Lead to Elimination NCT03776760 | Kirby Institute | — |
| Terminated | Motivational Interviewing for HCV Elimination NCT03804814 | Nova Scotia Health Authority | N/A |
| Unknown | Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer NCT05181826 | Helio Genomics | — |
| Completed | HCV and Co-morbid Alcohol Use Disorders: A Translational Investigation of Antiviral Therapy Outcomes on CNS Fu NCT03902366 | VA Office of Research and Development | — |
| Unknown | Conquering Hepatitis C Via Micro-Elimination in Southwest Virginia NCT03876470 | University of Virginia | — |
| Unknown | Micro-elimination of Hepatitis C Virus Infection in Uremics NCT03891550 | Kaohsiung Medical University Chung-Ho Memorial Hospital | Phase 3 |
| Completed | Evaluation of Hepatitis C Viral Load Quantification on DBS in Vietnam NCT03670251 | Institut Pasteur | N/A |
| Completed | Electronic Record Assimilation and Subsequent Eradication of Hepatitis C NCT04873609 | Stanford University | N/A |
| Completed | Multi-center Study to Transplant Hepatitis-C Infected Kidneys NCT03781726 | Raymond Chung | Phase 4 |
| Completed | HBV/HCV/HIV in Belgian Prisons NCT04366492 | Hasselt University | N/A |
| Unknown | Effect of Strategies for the Treatment of Chronic Hepatitis C in Colombia NCT03895294 | Universidad de Antioquia | N/A |
| Unknown | The Use of MRI Apparent Diffusion Coefficient Value (ADC Value) to Assess Liver Cirrhosis NCT03456440 | Assiut University | — |
| Completed | Bioequivalence Study of Crushed Elbasvir/Grazoprevir Compared to the Whole Tablet NCT03817619 | Radboud University Medical Center | Phase 1 |
| Completed | Utilization of Hepatitis C Positive Kidneys in Negative Recipients NCT03801707 | Ohio State University | Phase 2 / Phase 3 |
| Completed | Safety of Sofosbuvir in People With Advanced Kidney Failure NCT03883698 | Sanjay Gandhi Postgraduate Institute of Medical Sciences | Phase 3 |
| Completed | Behavioral Science and Hepatitis C Screening Outreach NCT03712553 | University of Pennsylvania | N/A |
| Completed | Counseling Hepatitis C Virus (HCV) Positive Patients for Cardiovascular Disease Risk Factors NCT03402334 | Tulane University | N/A |
| Withdrawn | Direct Acting Antiviral Therapy in Donor HCV-positive to Recipient HCV-negative Kidney Transplant NCT03623568 | Raymond T. Chung, MD | Phase 4 |
| Terminated | Pan-genotypic Direct Acting Antiviral Therapy in Donor HCV-positive to Recipient HCV-negative Lung Transplant NCT03625687 | Massachusetts General Hospital | Phase 4 |
| Completed | Hepatitis C: Community Testing and Treatment (CT2 Study Myanmar) NCT03939013 | Macfarlane Burnet Institute for Medical Research and Public Health Ltd | N/A |
| Completed | Simplified Monitoring Myanmar SM2 Study NCT04113629 | Kirby Institute | N/A |
| Completed | Surveillance of HCV in Uremics and Linking to Medical Care NCT03803410 | Kaohsiung Medical University Chung-Ho Memorial Hospital | — |
| Unknown | Epidemiology of Hepatitis B, C and Delta in Reunion Island NCT03362866 | Centre Hospitalier Universitaire de la Réunion | — |
| Withdrawn | A Prospective Cohort Study to Improve HCV Care in Dialysis Patients NCT03791814 | Albert Einstein Healthcare Network | Phase 4 |
| Unknown | Hepatitis C Patient Management and Family Health Education NCT03813498 | China Liver Health | N/A |
| Unknown | SOF/VEL±RBV: Efficacy and Safety in GT 3 and 6 HCV Patients NCT04948801 | Third Affiliated Hospital, Sun Yat-Sen University | — |
| Completed | Hepatocellular Carcinoma in HIV-infected Individuals in Asian Population NCT03702998 | Chinese University of Hong Kong | — |
| Unknown | Outcomes Mandate National Integration With Cannabis as Medicine NCT03944447 | OMNI Medical Services, LLC | Phase 2 |
| Withdrawn | Early Post-marketing Study of Daclatasvir (Daklinza®) + Asunaprevir (Sunvepra®) in the Treatment of Chronic He NCT03208322 | Bristol-Myers Squibb | — |
| Completed | Cardiovascular Disease in HIV and Hepatitis C: Risk Outcomes After Hepatitis C Eradication NCT03823911 | University of Maryland, Baltimore | Phase 4 |
| Completed | DRug Use & Infections in ViEtnam - Hepatitis C (DRIVE-C) NCT03537196 | ANRS, Emerging Infectious Diseases | Phase 4 |
| Completed | Understanding and Intervening With Heavy Drinking Among Patients With HIV and HCV NCT03652675 | New York State Psychiatric Institute | N/A |
| Completed | Reaching Out to the UNdiagnosed People Infected With Blood Borne Viral Infections NCT04363411 | Hasselt University | N/A |
| Completed | Monitoring SOF/VEL in Treatment Naïve, HCV Participants With Active Infection NCT03512210 | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | Phase 4 |
| Completed | Screening Hepatitis Positive Women for Congenital Anomalies NCT03980301 | Aljazeera Hospital | — |
| Withdrawn | Direct-acting Antiviral Therapy to Prevent HCV Infection for HCV Positive Donor to HCV Negative Recipient Kidn NCT03093740 | Massachusetts General Hospital | Phase 4 |
| Completed | An Observational Study of Maviret (Glecaprevir/Pibrentasvir) for Korean Chronic Hepatitis C Genotypes 1 to 6 P NCT03740230 | AbbVie | — |
| Completed | Renal Transplants in Hepatitis C Negative Recipients With Nucleic Acid Positive Donors NCT03627299 | Johns Hopkins University | Phase 4 |
| Completed | Evaluation Study of RDTs Detecting Antibodies Against HCV NCT04033887 | Foundation for Innovative New Diagnostics, Switzerland | — |
| Completed | HCV Seek, Test and Rapid Treatment for Young PWID NCT03627546 | Weill Medical College of Cornell University | N/A |
| Completed | STOP HCC: Mailed HCV Treatment Outreach Program for HCC Prevention NCT03706742 | University of Texas Southwestern Medical Center | N/A |
| Completed | Ask a Friend to Take a Test for Hepatitis C Infection NCT03697135 | NHS Tayside | — |
| Completed | Community Access, Retention in Care, and Engagement for Hepatitis C Treatment NCT03581383 | Jens Rosenau | N/A |
| Completed | Change of Glucose Metabolism and Fibrosis Markers in Patients With Hepatitis C Under Treatment With Antiviral NCT03908294 | Johann Wolfgang Goethe University Hospital | — |
| Unknown | Transplantation Using Hepatitis C Positive Donors, A Safety Trial NCT04017338 | Jordan Feld | Phase 3 |
| Unknown | Impact of Sustained Virologic Response on Glycemic Control Among Diabetic Patients With Hepatitis C Virus Rela NCT03591783 | Assiut University | — |
| Completed | Influence of Cola on the Absorption of the HCV Agent Velpatasvir in Combination With PPI Omeprazole. NCT03513393 | Radboud University Medical Center | Phase 1 |
| Withdrawn | Preemptive Zepatier Treatment in Donor HCV Positive to Recipient HCV Negative Cardiac Transplant NCT03026023 | Raymond T. Chung, MD | Phase 4 |
| Withdrawn | A Single-arm Evaluation of the Effect of HCV Treatment on Cardiovascular Disease Risk NCT03585101 | University of California, Los Angeles | Phase 4 |
| Completed | Safety and Effectiveness of PRI-724 for Hepatitis C or B Virus Derived Liver Cirrhosis NCT03620474 | Kiminori Kimura, MD | Phase 1 / Phase 2 |
| Terminated | Registry-based HCV Care Cascade Navigation at Atlanta's Grady Memorial Hospital NCT03441542 | National Opinion Research Center | N/A |
| Completed | Prevention of De Novo HCV With Antiviral HCV Therapy Post-Liver and Post-Kidney Transplant NCT03619837 | University of California, San Francisco | Phase 4 |
| Completed | Universal HIV Screening and Targeted HCV Screening in Emergency Department NCT03595527 | Centre hospitalier de l'Université de Montréal (CHUM) | N/A |
| Terminated | Mild Hypothermia and Acute Kidney Injury in Liver Transplantation NCT03534141 | University of California, San Francisco | N/A |
| Completed | T Regulatory Cells in Hepatitis c Infected Patients NCT03186235 | Assiut University | — |
| Terminated | Evaluation of Daclatasvir (DCV) in Combination With Sofosbuvir (SOF) in Children With Chronic Hepatitis C (CHC NCT03487848 | Bristol-Myers Squibb | Phase 2 |
| Completed | Transmission of Chronic Hepatitis C in Pregnancy NCT03570112 | The Christ Hospital | — |
| Completed | EBR/GZR for HCV-1b Patients Receiving Hemodialysis NCT03420300 | National Taiwan University Hospital | Phase 4 |
| Unknown | ETHOS ENGAGE: Enhancing Treatment of Hepatitis C in Opioid Substitution Settings NCT03685045 | Kirby Institute | N/A |
| Completed | A Study of the Use of Hepatitis C Positive Donors for Hepatitis C Negative Lung Transplant Recipients With Pos NCT03523871 | NYU Langone Health | Phase 2 |
| Completed | Crowdsourcing to Promote HBV and HCV Testing in China NCT03482388 | University of North Carolina, Chapel Hill | N/A |
| Completed | The Sublimated Mare Milk Supplement in Hepatitis C NCT03669835 | Asfendiyarov Kazakh National Medical University | N/A |
| Unknown | Hepatitis C (HCV) Cure and Kidney Health NCT03407703 | San Francisco Veterans Affairs Medical Center | — |
| Terminated | The Dublin Zepatier Study NCT02895958 | Mater Misericordiae University Hospital | Phase 4 |
| Completed | Direct Acting Antiviral-Post Authorization Safety Study NCT03707080 | Target PharmaSolutions, Inc. | — |
| Unknown | Grazoprevir and Elbasvir Without Ribavirin for 12 Weeks in Patients With HCV-related Cryoglobulinemic Nephropa NCT03433326 | University of Florence | — |
| Completed | Study of HIV, HCV, APS and Phylogenetics for PWID NCT03447210 | University of Washington | N/A |
| Completed | Response Guided Treatment With Direct Acting Anti-Viral Medications for Chronic HCV Infection NCT03603327 | Soroka University Medical Center | N/A |
| Completed | A Self-efficAcy Intervention to reDuce Injecting Risk behAviour and hePatitis c reinfecTion Rates NCT03293576 | University of Dundee | N/A |
| Withdrawn | Efficacy and Safety of Elbasvir/Grazoprevir in Brazilian Participants With Chronic Hepatitis C Virus (HCV) Gen NCT03143998 | Merck Sharp & Dohme LLC | Phase 4 |
| Completed | Effect of DAAs on Behavior of HCC in HCV Patients NCT03200171 | Al-Azhar University | — |
| Completed | P300 in Early Cognitive Impairment in Hepatitis C Virus NCT04389268 | Mansoura University Hospital | — |
| Unknown | The Staying Safe Intervention NCT03418636 | National Development and Research Institutes, Inc. | N/A |
| Completed | Eliminating Hepatitis C Virus NCT03401697 | Icahn School of Medicine at Mount Sinai | — |
| Completed | A Direct obserVed therApy vs fortNightly CollEction Study for HCV Treatment - ADVANCE HCV Study NCT03236506 | University of Dundee | Phase 2 |
| Unknown | Toward Elimination of Hepatitis C Virus (HCV): A Pilot Study NCT03364725 | Id Care | Phase 4 |
| Completed | Effects of Ledipasvir/Sofosbuvir on the Pharmacokinetics and Renal Safety of Tenofovir Alafenamide (TAF) NCT03126370 | University of Colorado, Denver | Phase 4 |
| Completed | Computer-based Intervention for Alcohol-using HIV/HCV+ Women NCT03362476 | New York University | N/A |
| Completed | Real-world Incidence Proportion of Hepatic Toxicity and All Adverse Drug Reactions (ADRs) in Japanese Patients NCT03071133 | Bristol-Myers Squibb | — |
| Unknown | Neuropsychiatric Adverse Effects in Patients With Chronic Hepatitis C Treated by Direct Acting Antiviral Drugs NCT03268317 | Assiut University | — |
| Unknown | Impact of DAA Uptake in Controlling HCV Epidemic and Modeling Interventions for HCV Elimination Among HIV-infe NCT03551002 | University of California, San Diego | — |
| Unknown | Effect of Direct-acting Antiviral Drugs on Erectile Function NCT03444272 | Sherief Abd-Elsalam | Phase 3 |
| Completed | Epidemiology of Hepatitis B, C and D and HIV Along the Maroni River Bordering French Guiana and Suriname (MaHe NCT05002907 | Centre Hospitalier de Cayenne | — |
| Unknown | Detection of Hepatitis C Infection by Oraquick Test Among Health Care Workers NCT03254901 | Assiut University | — |
| Completed | Simplified Antiviral Treatment Strategy for Hepatitis C in Myanmar NCT03579576 | Right to Care | — |
| Unknown | Grazoprevir/Elbasvir for Treatment of Hepatitis C Virus Genotype 4 Post Kidney Transplant NCT03359746 | King Faisal Specialist Hospital & Research Center | Phase 4 |
| Completed | Class II Invariant Chain HCV Vaccine Study NCT03688061 | University of Oxford | Phase 1 |
| Unknown | Assessment of Patients With Hepatitis C Virus Related Liver Cirrhosis After Sustained Response to Direct Actin NCT03241823 | Assiut University | — |
| Completed | Evaluation of Treatment of Chronic HCV Patients in Chronic Kidney Disease Versus End Stage Renal Disease Patie NCT03341988 | Assiut University | Phase 1 |
| Terminated | DAA Treatment in Donor HCV-positive to Recipient HCV-negative Liver Transplant NCT03208127 | Massachusetts General Hospital | Phase 4 |
| Completed | Smartphone Based aDOT Treatment With Fixed-Dose Elbasvir and Grazoprevir in PWIDs NCT03127358 | Albert Einstein College of Medicine | N/A |
| Completed | Study of the Effectiveness and Clinical Practice Use of Glecaprevir Plus Pibrentasvir in Patients With Chronic NCT03303599 | AbbVie | — |
| Terminated | DAA Treatment in Donor HCV-positive to Recipient HCV-negative Heart Transplant NCT03208244 | Massachusetts General Hospital | Phase 4 |
| Completed | Sexual Hepatitis C in HIV Positive Men Who Have Sex With Men (MSM) in Bordeaux NCT03290755 | University Hospital, Bordeaux | — |
| Unknown | The Effect of Direct Antiviral Therapy on Hepatitis c Virus-related Thrombocytopenia NCT03169348 | Assiut University | N/A |
| Unknown | Determining the Sustained Virologic Response of Declatasvir in Egyptian Patients With Hepatitis C Virus Genoty NCT02772744 | Zagazig University | — |
| Completed | Effect of Hepatitis C Clearance on Insulin Resistance NCT04457050 | Alexandria University | Phase 4 |
| Completed | Hepatitis C Education for Pregnant Women With Opiate Dependence - Phase 2 NCT03320889 | TriHealth Inc. | N/A |
| Suspended | Bariatric Embolization of Arteries in Obese Patients With HCC to Allow Salvage Liver Transplantation NCT02935478 | St. Louis University | N/A |
| Completed | A Pilot Study of Treating HCV at a Psychiatrist-staffed Outpatient Addiction Clinic NCT03235154 | Community Research Initiative of New England | Phase 4 |
| Completed | Hyalornic Acid Level in β-Thalassemic Children Treated for Hepatitis C Virus NCT03961828 | Tanta University | Phase 4 |
| Completed | Helping Empower Liver and Kidney Patients NCT03426787 | Washington University School of Medicine | N/A |
| Active Not Recruiting | Lung Transplant HCV, Pilot Study NCT03112044 | University Health Network, Toronto | EARLY_Phase 1 |
| Completed | Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metfor NCT03686722 | Mohamed Raslan | Phase 1 |
| Completed | Effects of Health Literacy and HCV Knowledge on HCV Treatment Willingness in HIV-coinfected Patients NCT03413696 | University of California, San Diego | — |
| Completed | Harvoni Treatment Porphyria Cutanea Tarda NCT03118674 | Wake Forest University Health Sciences | Phase 2 |
| Completed | Hepatitis C Virus Detection in Oral Squamous Cell Carcinoma NCT03109457 | Cairo University | — |
| Terminated | Impact of Hepatitis C Therapy and Bone Health NCT03221582 | Dallas VA Medical Center | Phase 4 |
| Completed | Hepatitis C Virus Donor Positive Kidney Transplantation for Hepatitis C Virus Negative Recipients NCT03249194 | Virginia Commonwealth University | EARLY_Phase 1 |
| Unknown | Effects of Direct Antiviral Agents on Hepatitis C Virus Arthropathy NCT03226717 | Assiut University | — |
| Unknown | HepCare: The Effectiveness of Community Based Interventions With Peer Support to Improve Case Detection, Carry NCT03524794 | University College, London | — |
| Active Not Recruiting | Expanding the Pool in Orthotopic Heart Transplantation NCT03222531 | Mary E. Keebler, MD | Phase 2 |
| Completed | Hepatitis C Education for Pregnant Women With Opiate Addiction - Phase 1 NCT03245931 | TriHealth Inc. | — |
| Completed | Accessible HCV Care Intervention for People Who Inject Illicit Drugs (PWID) NCT03214679 | City University of New York, School of Public Health | N/A |
| Unknown | HCV RAS Testing in Public Health Programs NCT04242433 | Post Graduate Institute of Medical Education and Research, Chandigarh | — |
| Terminated | A First in Human Study of AL-611 in Healthy Volunteers and Patients With Hepatitis C Virus Infection NCT03253471 | Alios Biopharma Inc. | Phase 1 |
| Completed | Study of AT-527 in Healthy and HCV-Infected Subjects NCT03219957 | Atea Pharmaceuticals, Inc. | Phase 1 |
| Completed | Rapid Point-of-care Testing for Hepatitis C in Community Clinics (RAPID-EC) Pilot Study NCT03231930 | Macfarlane Burnet Institute for Medical Research and Public Health Ltd | N/A |
| Recruiting | Project I Test: Implementing HIV Testing in Opioid Treatment Programs NCT03135886 | Columbia University | N/A |
| Unknown | Application of 18F-FDOPA PET and Magnetic Resonance Spectroscopy (MRS) With HCV and PD NCT03973502 | National Taiwan University Hospital | N/A |
| Completed | Tool to Improve Treatment Adherence and Outcomes at Grady Liver Clinic NCT03831555 | Emory University | N/A |
| Completed | Retrospective Efficacy and Safety Study With Elbasvir/Grazoprevir in HCV-infected Patients With Chronic Kidney NCT03145623 | University Hospital, Toulouse | — |
| Completed | Maraviroc Efficacy for Hepatitis C NCT02881762 | University of Maryland, Baltimore | Phase 4 |
| Unknown | Hepatitis c and Vitamin D and Iron Status NCT03166280 | Eman Sayed Hassan Abd Allah | — |
| Completed | Identification to Elimination in HCV-Infected Individuals NCT03195205 | TruCare Internal Medicine & Infectious Disease | EARLY_Phase 1 |
| Completed | Hepatitis C Treatment in PWIDs: MAT or Syringe Exchange Assisted-therapy vs Standard of Care NCT03093415 | Oregon Health and Science University | Phase 4 |
| Recruiting | Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional NCT05361603 | University Hospital, Limoges | — |
| Completed | Vertical Transmission of Hepatitis C in Adult Children of Female Baby Boomers NCT03038763 | University of Pennsylvania | — |
| Unknown | Impact of Insulin Resistance on Therapeutic Response for Oral Treatment of Chronic Hepatitis C Virus Infection NCT03212833 | Assiut University | — |
| Completed | HCV Treatment Immune Response With Grazoprevir/Elbasvir Before or After Renal Transplant NCT02902120 | University of Maryland, Baltimore | Phase 4 |
| Terminated | Scale-up of Treatment of Hepatitis C Infection Among People Who Inject Drugs NCT02940691 | Kirby Institute | Phase 4 |
| Completed | Sofosbuvir/Ledipasvir for Hepatitis C Genotype 1-6 in Patients With Transfusion-Dependent Thalassemia: An Open NCT03032666 | Ala'a Sharara | Phase 4 |
| Unknown | Efficacy of GZR/EBR in Early Chronic Hepatitis C in HIV/HCV Co-infected Patients NCT02897596 | Fundacion Clinic per a la Recerca Biomédica | Phase 3 |
| Completed | Study to Assess Clinical Outcomes in Chronic Hepatitis C Patients Previously Treated With Daclatasvir-Based Re NCT03366610 | Bristol-Myers Squibb | — |
| Completed | Multi-Center, Randomized, Open-Label Study of G/P +/- RBV for NS5A + SOF Previously Treated GT1 HCV Subjects NCT03092375 | University of Florida | Phase 3 |
| Unknown | Strategic Screening for Infectious Diseases (Tuberculosis, HIV, HBV, HCV) Amongst Migrants in France NCT02959684 | University Paris 7 - Denis Diderot | — |
| Completed | Increasing Uptake of Evidence-Based Screening Services Through CHW-led Multi-modality Intervention NCT02970136 | University of Miami | N/A |
| Terminated | A Long Term Follow-up Study in Participants Treated in a Preceding Phase 2 or 3 Study With a Regimen Containin NCT03099135 | Janssen Research & Development, LLC | Phase 3 |
| Completed | Direct Acting Agents in Hepatitis C Patients NCT03145844 | Fehmi Tabak | — |
| Completed | Pilot Study of HIV and Hepatitis B and C Screening in Surgery NCT03088995 | Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida | — |
| Completed | Effectiveness, Safety and Clinical Outcomes of Elbasvir/Grazoprevir: Results From a Spanish Real World Cohort NCT03111966 | Hepa C | — |
| Completed | Randomised Study of Interferon-free Treatment for Recently Acquired Hepatitis C in PWID and People With HIV Co NCT02625909 | Kirby Institute | Phase 3 |
| Unknown | Transplanting Hepatitis C Positive Organs NCT03086044 | Brigham and Women's Hospital | Phase 4 |
| Unknown | Treatment of Hepatitis C Virus Infection With Generic Sofosbuvir/Ledipasvir in Iranian Patients NCT03061032 | Iran Hepatitis Network | Phase 3 |
| Unknown | Study of the Early Occurrence of Hepatocellular Carcinoma (HCC) in Egyptian HCV Infected Patients Receiving So NCT03247296 | MTI University | — |
| Completed | Comparison of Telemedicine to Usual Care for HCV Management for Methadone-maintained Individuals NCT02933970 | Andrew Talal | N/A |
| Completed | Epidemiology of Chronic Hepatitis C and Disease Modelling NCT03566563 | Changi General Hospital | — |
| Completed | HCV Group Evaluation and Treatment Uptake (HCV GET-UP) Intervention NCT03242655 | Montefiore Medical Center | N/A |
| Completed | The Impact on Linkage-to-care of an Alternative Hepatitis C Screening Method in PWID NCT02971488 | Hospital Universitario Infanta Leonor | — |
| Completed | Accelerated Pre-treatment Evaluation for HCV Infected Persons Who Inject Drugs NCT02755402 | Centre hospitalier de l'Université de Montréal (CHUM) | N/A |
| Completed | Prevalence of Hepatitis c Virus Infection Among Rheumatological Patients NCT03587714 | Assiut University | — |
| Completed | Project MATLINK: Development and Evaluation of a Screening, Brief Intervention, & Referral to Treatment (SBIRT NCT04947475 | Yale University | N/A |
| Completed | Genome Studies of Hepatocellular Carcinoma Developed in Hepatitis C Patients With Sustained Virological Respon NCT03254121 | Karolinska Institutet | — |
| Unknown | Serum Alpha-fetoprotein Levels and Response to Direct Antiviral Therapy in Patients With Chronic Hepatitis C NCT03402165 | Sherief Abd-Elsalam | Phase 4 |
| Completed | A Peer-based Mobile-health Intervention to Increase Access & Adherence to Hepatitis C Treatment & HIV Viral Su NCT02772328 | Johns Hopkins Bloomberg School of Public Health | N/A |
| Completed | Real World Experience of Chronic Hepatitis C (CHC) Treatment in Israel NCT03144440 | Carmel Medical Center | — |